Warning against “genetic over-diagnosis” in breast cancer screening
It is unjustified and potentially harmful to screen women for genes whose connection to breast cancer has yet to be proven, says an international team of leading geneticists and oncologists.
Pioneering effort to apply novel biotechnology to cancer research
The effort to find new biomarkers for cancer has received a major boost with the recent arrival at Lady Davis Institute of Dr. Christoph Borchers and the development of the first pan-Canadian proteomics program.
New revelations about a possible pathway to Alzheimer’s disease
Elevated levels of a particular protein, known as Capase-6, in a specific area of the brain can serve as an early indicator for the onset of the type of cognitive impairment that is characteristic of Alzheimer’s disease.